EUCRU Eucrates Biomedical Acquisition Corp - Units (1 Ord & 1/3 War)

Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.  This security was issued by Eucrates Biomedical Acquisition Corp. , whose common stock symbol is EUCR.

$10.06  +0.11 (1.11%)
As of 10/07/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Units
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  10/22/2020
Outstanding shares:  10,350,000
Average volume:  675
Market cap:   $131,898,079
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy